Centaur Pharmaceuticals Private Limited, a active private limited company, was established on 15 October 1980 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24230MH1980PTC023291. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹20.00 Cr and a paid-up capital of ₹18.50 Cr.
Formerly known as Centaur Pharmaceuticals Limited. It upholds a compliant status. Employing 3,274 professional, Its leadership includes Rakhi Shridhar Kadam (Whole-Time Director), Shivanand Dattatraya Sawant (Managing Director), Sharadchandra Damodar Abhyankar (Director). Past directors included Rakhi Shridhar Kadam, Sajit Kumar, Prabhakar Mahadeo Thakoor. It holds ₹308.00 Cr open charges and ₹239.90 Cr settled loans. Its latest AGM occurred on 13 August 2025, with the balance sheet filed on 31 March 2025. It is based at Centaur House, Shanti Nagar, Vakola, Santacruz (E),, Mumbai, Maharashtra, 400055.
U24230MH1980PTC023291
023291
15 October 1980
₹20.00 Cr
₹18.50 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Centaur Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakhi Shridhar Kadam | Whole-Time Director | 14 Sep 2015 | Current |
| Shivanand Dattatraya Sawant | Managing Director | 15 Oct 1980 | Current |
| Sharadchandra Damodar Abhyankar | Director | 11 Aug 2016 | Current |
| Supriya Samar Desai | Whole-Time Director | 21 Dec 2021 | Current |
| Albert Taura | Director | 11 Aug 2016 | Current |
| Smita Abhayakumar Phal | Whole-Time Director | 22 Jun 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 24 Mar 2015 | Past |
| Pramod Abcsdd | Nominee Director | 03 Apr 2014 | Past |
| Pramod Abcsdd | Director | 23 Oct 2008 | Past |
| Pramod Abcsdd | Director | 08 Jun 2015 | Past |
| Pramod Abcsdd | Nominee Director | 21 Apr 2011 | Past |
| Pramod Abcsdd | Additional Director | 25 Aug 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Centaur Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.18% decrease. The company also saw a substantial fall in profitability, with a 42.94% decrease in profit. The company's net worth Soared by an impressive increase of 12.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Centaur Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,080,000,000.00
₹2,399,020,215.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2011 | State Bank Of India | ₹154.00 Cr | Open |
| 03 Aug 2006 | State Bank Of India | ₹154.00 Cr | Open |
| 26 May 2015 | Tata Capital Financial Services Limited | ₹1.70 Cr | Satisfied |
| 27 Jan 2015 | Tata Capital Financial Services Limited | ₹3.00 Cr | Satisfied |
| 19 May 2014 | Tata Capital Financial Services Limited | ₹12.50 Cr | Satisfied |
Explore comprehensive loan charge details -
Centaur Pharmaceuticals has a workforce of 3274 employees as of Oct 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Centaur Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centaur Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Centaur Pharmaceuticals Private Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records. was documented.
The activity Centaur Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Progress on Supriya Samar Desai was appointed as a Whole-time director was appointed as a Whole-time director on 21 Dec 2021 & has been associated with this company since 3 years 11 months . was documented.
The activity A charge with State Bank Of India of Rs. 154.00 Cr registered on 03 Aug 2006 with Charge ID 10015268 was modified on 28 Oct 2020. was completed.
The activity A charge with State Bank Of India of Rs. 154.00 Cr registered on 03 May 2011 with Charge ID 10291402 was modified on 24 Feb 2020. was completed.
Sharadchandra Damodar Abhyankar was appointed as a Director was appointed as a Director on 11 Aug 2016 & has been associated with this company since 9 years 4 months . was recorded as a recent event.
Mumbai, September 10, 2019: LifeSan Clinical Research, the clinical research division of Centaur Pharmaceuticals was audited by the US FDA and was concluded with zero 483 observations which signifies.
The CIN of Centaur Pharmaceuticals Private Limited is U24230MH1980PTC023291.
Centaur Pharmaceuticals Private Limited is headquartered at Centaur House, Shanti Nagar, Vakola, Santacruz (E),, Mumbai, Maharashtra, 400055.
Centaur Pharmaceuticals Private Limited was incorporated on 15 October 1980.
The current directors of Centaur Pharmaceuticals Private Limited are
The primary industry of Centaur Pharmaceuticals Private Limited is Manufacturing.
Centaur Pharmaceuticals Private Limited is unlisted.
The authorized capital of Centaur Pharmaceuticals Private Limited is ₹20.00 Cr, and the paid-up capital is ₹18.50 Cr.
The compliance status of Centaur Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX